Nuacht

Frédéric Cren, directeur général et cofondateur d’Inventiva, présentera un aperçu stratégique de la Société lors d'un fireside chat dans le cadre de la « Jefferies Global Healthcare Conference » qui ...
Inventiva’s management will also participate in the UBS Spring Biotech Conference which will take place in New York on June 24th, 2025.
The Dr. Jeremy Saul Scholarship for Medical Students is now officially open for applications, offering aspiring undergraduate students across the United States the opportunity to receive a one-time ...
The Dr. David Webb Scholarship for Future Doctors is now accepting applications from students across the United States who are dedicated to building careers in healthcare. Spearheaded by Dr. David ...
Goldman Sachs 46th Annual Global Healthcare Conference Richard Francis, President & CEO Tuesday, June 10, 2025, at 8:00 am ET To access a live webcast of the presentation, visit Teva’s Investor ...
Location: ASCP 2025 Annual Meeting, Fairmont Scottsdale Princess Salon Ballroom H, Scottsdale, AZ ...
Webcasts of the discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.
On May 27, 2025, the Board of Directors of Galapagos approved “Subscription Right Plan 2025 (A)”, intended for personnel of the Company, within the framework of the authorized capital. Under this ...
Replays of the webcasts will be available in the investor section of the company's website at https://ir.bioagelabs.com/, and will be archived for 30 days following the presentations. About BioAge ...
Date: Tuesday, June 10, 2025 Time: 4:30pm Eastern Time (1:30pm Pacific Time) U.S. dial-in number: 877-407-0789 International number: 201-689-8562 Webcast: 4Q Earnings Webcast ...
PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 ...
Assembly Biosciences is a biotechnology company dedicated to the development of innovative small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of ...